Efficacy of 2 Probiotics During Nicotine Replacement Therapy on Withdrawal Symptoms Associated With Smoking Cessation
NCT02492022 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 75
Last updated 2016-02-18
Summary
Quitting smoking is a big decision, a decision to achieve better health. Trying to quit smoking can be stressful. The prospect of dealing with withdrawal symptoms, fear or failure to change the routine, can also be sources of stress.
Withdrawal from nicotine is characterized by symptoms that include anxiety, irritability, hunger and cravings for more tobacco. Nicotine creates a dependency so that the body develops a need for a certain level of nicotine at all times. Unless that level is maintained symptoms of withdrawal appear.
For tobacco users trying to quit, symptoms of withdrawal from nicotine are unpleasant and stressful, but they are temporary.
Research has demonstrated the relative effectiveness of pharmacotherapy treatments in smoking cessation but no studies have examined the effects of the probiotics on the withdrawal symptoms associated with the tobacco cessation during nicotine replacement therapy (NRT).
The purpose of this study is to assess the effectiveness of two probiotic products during NRT for managing withdrawal symptoms associated with smoking cessation.
Conditions
- Smoking Cessation
Interventions
- DIETARY_SUPPLEMENT
-
Probiotic L008-1
Dosing regimen of 2 capsules daily, once per day, for 14 weeks
- DIETARY_SUPPLEMENT
-
Probiotic L008-2
Dosing regimen of 2 capsules daily, once per day, for 14 weeks
- OTHER
-
Placebo
Dosing regimen of 2 capsules daily, once per day, for 14 weeks
Sponsors & Collaborators
-
MedQualis
collaborator INDUSTRY -
Q & T Research
collaborator UNKNOWN -
Lallemand Health Solutions
lead INDUSTRY
Principal Investigators
-
Luc Larrivée, MD · Q & T Research
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
Countries
- Canada
Study Locations
More Related Trials
-
Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving
NCT01466361 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Cannabidiol for Tobacco Cessation
NCT05445804 ·Status: RECRUITING ·Phase: PHASE1
-
Trial of Cytisine in Adult Smokers
NCT03709823 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2
NCT00136838 ·Status: COMPLETED ·Phase: NA
-
Smoking Reduction or Cessation With Nicotine Replacement Therapy
NCT00840242 ·Status: COMPLETED ·Phase: PHASE3
-
Maintaining Nonsmoking: Older Smokers - 1
NCT00086385 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
NCT00710034 ·Status: COMPLETED ·Phase: PHASE2
-
Baclofen for Smoking Cessation in a Non-Psychiatric Population
NCT01228994 ·Status: TERMINATED ·Phase: PHASE2
-
Maintaining Abstinence in Chronic Cigarette Smokers - 1
NCT00087880 ·Status: COMPLETED ·Phase: PHASE2
-
Sensorimotor Replacement With Electronic and De-nicotinised Cigarettes
NCT01414998 ·Status: COMPLETED ·Phase: NA
-
Test of Novel Drug for Smoking Cessation
NCT02217527 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Nicotine Pouches Among Daily Smokers
NCT06043362 ·Status: RECRUITING ·Phase: NA
-
Cannabidiol for Reducing Cigarette Use
NCT06218056 ·Status: RECRUITING ·Phase: PHASE2
-
Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Therapy and Nicotine Gum
NCT01368016 ·Status: COMPLETED ·Phase: NA
-
A Follow-up Study to Assess Long-term Immunogenicity and Safety of NicVAX/Placebo as an Aid to Smoking Cessation
NCT01304810 ·Status: COMPLETED
-
Nicotine Replacement Therapy in Nicotine-dependent Arrestees
NCT02905734 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of the Electronic Cigarette on Withdrawal Symptoms
NCT01454362 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Bupropion in Treating Marijuana Dependent Individuals
NCT00142870 ·Status: COMPLETED ·Phase: PHASE2
-
Novel Medication as a Potential Smoking Cessation Aid
NCT02265367 ·Status: COMPLETED ·Phase: NA
-
e-Cigarettes Versus NRT Gum for Smoking Cessation
NCT01925781 ·Status: TERMINATED ·Phase: PHASE4
-
Oral Tolerability Of Two Nicotine Dosage Forms
NCT00682461 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement
NCT02439944 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge
NCT01075659 ·Status: COMPLETED ·Phase: PHASE2
-
E-cigarettes and Blood Vessel Function
NCT02740595 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Bupropion for Treating Nicotine Dependence in Young People
NCT00129272 ·Status: COMPLETED ·Phase: PHASE2